A 39-year-old woman with a history of human immunodefi ciency virus (HIV) and hepatitis B virus infection was brought to the emergency department for evaluation of seizures, which had started a few days earlier. She was born and raised in a state bordering the Ohio River, an area where Histoplasma capsulatum is endemic. She denied any recent travel.
FIGURE 1. (A)
Axial contrast-enhanced T1-weighted magnetic resonance imaging showed ring-enhancing lesions (white arrows), while (B) axial T2-weighted images showed ring-enhancing lesions surrounding hyperintensity, consistent with vasogenic edema (white arrows).
She has poorly controlled HIV, seizures, and brain lesions; is it Histoplasma or Toxoplasma? BARBARYAN AND COLLEAGUES
During her hospital course, she underwent brain biopsy via right frontotemporal craniotomy with resection of right frontal lesions. Pathologic study showed partially organizing abscesses with central necrosis (Figure 2) , microscopy with Grocott-Gomori methenamine silver stain was positive for budding yeast forms consistent with H capsulatum (Figure 3) , and special stain for acid-fast bacilli was negative for mycobacteria. Cultures of the brain biopsy specimen, blood, and cerebrospinal fl uid for fungi, acid-fast bacilli, and bacteria did not reveal any growth after 28 days.
The patient was discharged home with instructions to take amphotericin B for a total of 6 weeks and then itraconazole. About 1 year later, she remained free of symptoms, although repeat MRI did not show any signifi cant change in the size or number of histoplasmomas.
She did not comply well with her HIV treatment, and her immune status did not improve, so we decided to continue her itraconazole treatment for more than 1 year.
■ CEREBRAL HISTOPLASMOMA
The term "histoplasmoma" was introduced by Shapiro et al 1 in 1955, when they fi rst described numerous focal areas of softening, up to 1 cm in diameter, scattered throughout the brain at autopsy in a 41-year-old man who had died of disseminated histoplasmosis. They coined the word to describe these discrete areas of necrosis that might resemble tumors on the basis of their size, location, and capability of causing increased intracranial pressure.
Central nervous system involvement can either be a manifestation of disseminated disease or present as an isolated illness. 2 It occurs in 5% to 10% of cases of disseminated histoplasmosis. 3 Histoplasmosis of the central nervous system can have different manifestations; the most common presentation is chronic meningitis. 4 Laboratory diagnosis is based on detecting H capsulatum antigen and antibody in the urine, blood, and cerebrospinal fl uid. Tissue biopsy (histopathology) as well as cultures of tissue samples or body fl uids may also establish the diagnosis. 4 Toxoplasmosis and primary central nervous system lymphoma are the most common causes of brain ring-enhancing lesions in HIV patients in developed countries, while in the developing world neurocysticercosis and tuberculomas are more common. 5, 6 Much less common causes include brain abscesses secondary to bacterial infections (pyogenic abscess), 7 cryptococcomas, 8 syphilitic cerebral gummata, 9 primary brain tumors (gliomas), and metastases. 10 Compared with other forms of the disease, histoplasmosis of the central nervous system has higher rates of treatment failure and relapse, so treatment should be prolonged and aggressive. 2, 3 The cure rate with amphotericin B ranges from 33% to 61%, and higher doses produce better response rates. 11 Liposomal amphotericin B is the drug of choice because it achieves higher concentrations in the central nervous system than other drugs and is less toxic. It is given for 4 to 6 weeks, followed by itraconazole for at least 1 year and until the cerebrospinal fl uid Histoplasma antigen test is negative and other cerebrospinal fl uid abnormalities are resolved.
In patients who have primary disseminated histoplasmosis that includes the cenItraconazole can be continued long-termlifelong if necessary (2), and the normal-appearing brain tissue (3) (hematoxylin and eosin, × 4).
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tral nervous system, itraconazole can be given for more than 1 year or until immune recovery is achieved-or lifelong if necessary. 2, 12 Long-term suppressive antifungal therapy also should be considered in patients for whom appropriate initial therapy fails. 2 Nephrotoxicity (acute kidney injury, hypokalemia, and hypomagnesemia), infusionrelated drug reactions, and rash are among the well-described side effects of amphotericin B. Maintenance of intravascular volume and replacement of electrolytes should be an integral part of the amphotericin B treatment regimen.
■ TAKE-AWAY POINTS
• Histoplasmomas should be considered in the differential diagnosis of ring-enhancing lesions of the central nervous system, along with toxoplasmosis and primary central nervous system lymphoma. This will allow timely initiation of the diagnostic workup, avoiding unnecessary and potentially risky interventions and delays in starting targeted antifungal therapy.
• There is no single gold standard test for central nervous system histoplasmosis. Rather, the fi nal diagnosis is based on the combination of clinical, laboratory, and radiologic fi ndings. 
